VENOUS THROMBOSIS

Type: Keyphrase
Name: VENOUS THROMBOSIS
First reported Aug 19 2014 - Updated Aug 19 2014 - 1 reports

Bluegrass Vascular Technologies Raises $4.5 Million Series A Financing

— Bluegrass Vascular Technologies closed $4.5 million in Series A financing, that will allow the company to obtain CE mark for the Surfacer Inside-Out Access Catheter System. Funds will also be used to enhance manufacturing capabilities, and proceed with ... [Published Diagnostic & Invasive Cardiology - Aug 19 2014]
First reported Aug 18 2014 - Updated Aug 18 2014 - 1 reports

Bellingham's NW Vascular Lab acquired by Bothell company

Below is a news release about a vascular testing company from Bothell purchasing a Bellingham lab:Pacific Vascular, Inc., the largest provider of vascular ultrasound testing in the Northwest, has acquired NW Vascular Lab in Bellingham, effective Saturday, ... [Published Bellingham Herald - Aug 18 2014]
First reported Aug 16 2014 - Updated Aug 16 2014 - 1 reports

The truth about liposuction and its dangers

An increasing number of people consider cosmetic surgery to be a quick-fix solution. It may sound like a minor procedure, but people should be warned that it can go wrong, and there are enormous risks involved.Liposuction often involves far more than ... [Published The Nation.lk - Aug 16 2014]
First reported Aug 12 2014 - Updated Aug 12 2014 - 1 reports

Central venous thrombosis and thrombophilia in cystic fibrosis

“The aims of this study were to (1) document the frequency of catheter venous thrombosis detected by colour-Doppler- ultrasound (Doppler-US), (2) assess genetic and acquired thrombophilia risk factors for catheter venous thrombosis and hypercoagulability ... [Published IVTEAM - Aug 12 2014]
First reported Aug 03 2014 - Updated Aug 03 2014 - 1 reports

Connection between Type 1 Diabetes and Ulcerative Colitis?

Patients with ulcerative colitis (UC) are usually prescribed corticosteroids to manage the inflammation associated with the disease, but when the patient has type 1 diabetes, it becomes even more difficult to manage both diseases simultaneously.Researchers ... [Published Diabetes in Control - Aug 03 2014]
First reported Jul 30 2014 - Updated Jul 30 2014 - 1 reports

Bluegrass Vascular Technologies Raises $4.5M Series A Financing Led By Targeted Technology Funds

SAN ANTONIO"The Surfacer System addresses a significant unmet clinical need in the vascular access market by allowing physicians to gain access through a previously occluded vein," stated Alan DeanThe Targeted Technology Fund is a venture capital firm ... [Published Bio-Medicine - Jul 30 2014]
First reported Jul 27 2014 - Updated Jul 27 2014 - 2 reports

New mercury detectionsystem devised

Device to prevent DVT made in IranScience & Technology DeskResearchers at Tehran’s Amirkabir University of Technology have produced electrical stimulation device to inhibit deep vein thrombosis (DVT) and varicose veins.Venous thrombosis is associated ... [Published Iran Daily - Jul 27 2014]
First reported Jul 24 2014 - Updated Jul 24 2014 - 1 reports

The mTORC Pathway in the Antiphospholipid Syndrome

This article has no abstract; the first 100 words appear below. The antiphospholipid syndrome is an acquired autoimmune disorder characterized by thrombotic events, miscarriages, and elevated levels of antiphospholipid antibodies.1 The syndrome is described ... [Published DailyMe.Com - Jul 24 2014]
First reported Jul 22 2014 - Updated Jul 22 2014 - 1 reports

Risk Factors Associated With Retinal Vein Occlusion

Squizzato A, Manfredi E, Bozzato S, Dentali F, Ageno W. Antithrombotic and fibrinolytic drugs for retinal vein occlusion: a systematic review and a call for action. Thromb Haemost 2010; 103: 271–6.Karia N. Retinal vein occlusion: pathophysiology and treatment ... [Published Theheart.org - Jul 22 2014]
First reported Jul 17 2014 - Updated Jul 17 2014 - 1 reports

Deep Venous Thrombosis: The “Economy Class Syndrome”

US Pharm . 2014;39(7):39-42.ABSTRACT: Deep venous thrombosis (DVT) can be precipitated by prolonged sitting during air travel. As the number of passengers traveling on long-haul flights continues to increase, so does the incidence of DVT. Various measures ... [Published U.S.Pharmacist - Jul 17 2014]
First reported Jul 17 2014 - Updated Jul 17 2014 - 1 reports

Glucose control complicates therapy for UC patients with type 1 diabetes

Treating ulcerative colitis in patients with type 1 diabetes presents numerous challenges as commonly prescribed corticosteroids can affect glucose control, and the diseases share other comorbidities.Researchers surveyed existing studies and discussed ... [Published Orthopedics Today - Jul 17 2014]
First reported May 22 2014 - Updated May 22 2014 - 1 reports

Isis Pharmaceuticals Reports Positive Phase 2 Data for ISIS-FXI Rx in the Prevention of Venous Thrombosis in Patients Undergoing Total Knee Replacement Surgery

CARLSBAD, Calif., May 22, 2014 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced today positive top-line data from a Phase 2 comparator-controlled study evaluating the incidence of venous thrombolic events (VTE) in patients treated ... [Published PR Newswire: Health - May 22 2014]

Quotes

...and take us one step closer to providing a better solution for patients with venous obstruction," commented Jim Clifton, CEO of Bluegrass Vascular. "The Targeted Technology Funds have a strong track record of bringing ground-breaking medical technology to market. We are pleased they share our vision for the Surfacer System and we look forward to commercializing the product in Europe and United States."
"Embodiments may further provide a method of exchanging heat with an extremity of a mammal to aid in the placement or advancement of a device into a vascular structure of the mammal and/or controlling body temperature in a mammal, comprising positioning an extremity of a mammal in an internal region that is formed using one or more walls of a body element, disposing one or more thermal exchanging units in proximity to a surface of the extremity that is positioned within the internal region, controlling the temperature of the one or more thermal exchange units, and/or regulating the temperature of IV fluid through use of at least one of the thermal exchange units. Methods may further comprise feeding a portion of an IV tube through an aperture in the body element. Methods may also comprise adjusting the pressure in the internal region to cause one of the one or more walls to urge at least one of the one or more thermal exchange units against the surface of the extremity. Moreover, methods may comprise sealing a portion of the body element to the extremity to enclose the internal region. Additionally, methods may comprise applying a compression force to the extremity of the mammal."

More Content

All (27) | News (22) | Reports (0) | Blogs (5) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
Identification and basic management of bleeding... [Published American Board of Family Practice - Aug 20 2014]
Bluegrass Vascular Technologies Raises $4.5 Mil... [Published Diagnostic & Invasive Cardiology - Aug 19 2014]
Bellingham's NW Vascular Lab acquired by Bothel... [Published Bellingham Herald - Aug 18 2014]
Detailed guide: DVLA’s current medical guidelin... [Published Government UK - Aug 18 2014]
The truth about liposuction and its dangers [Published The Nation.lk - Aug 16 2014]
Central venous thrombosis and thrombophilia in ... [Published IVTEAM - Aug 12 2014]
Connection between Type 1 Diabetes and Ulcerati... [Published Diabetes in Control - Aug 03 2014]
Bluegrass Vascular scores $4.5 mln Series A [Published PE Hub Blog - Jul 30 2014]
Bluegrass Vascular Technologies Raises $4.5M Se... [Published Bio-Medicine - Jul 30 2014]
Bluegrass Vascular Technologies Raises $4.5M Se... [Published BusinessWeek - Jul 30 2014]
New mercury detectionsystem devised [Published Iran Daily - Jul 27 2014]
New world record for electrical current [Published Iran Daily - Jul 27 2014]
The mTORC Pathway in the Antiphospholipid Syndrome [Published DailyMe.Com - Jul 24 2014]
Multi-Tissue Omics Analyses Reveal Molecular Re... [Published Plosone.org - Jul 22 2014]
Risk Factors Associated With Retinal Vein Occlu... [Published Theheart.org - Jul 22 2014]
Deep Venous Thrombosis: The “Economy Class Synd... [Published U.S.Pharmacist - Jul 17 2014]
Glucose control complicates therapy for UC pati... [Published Orthopedics Today - Jul 17 2014]
Patent Issued for Methods and Apparatus for Enh... [Published 4 Traders - Jul 17 2014]
Payment and Delivery Reform Case Study: Cancer ... [Published Brookings Latest From Brookings - Jul 07 2014]
Momenta Pharmaceuticals Receives Orphan Drug De... [Published GlobeNewswire - Jun 05 2014]
Isis Pharmaceuticals Reports Positive Phase 2 D... [Published PR Newswire: Health - May 22 2014]
GMO Vaccine-Strain Measles vs Cancer [erv] [Published ScienceBlogs : Combined Feed - May 16 2014]
JTB Law Group Commences TVM Lawsuit as FDA Prop... [Published PRWeb - Apr 30 2014]
Affinity Biologicals Inc. Now Offers a Complete... [Published PR.com Press Releases - Mar 26 2014]
US FDA accepts Regado Biosciences' investigatio... [Published PharmaBiz - Feb 18 2014]
StromAb, First-In-Class Antibody Dissolves Thro... [Published PRWeb - Nov 21 2013]
The Skikos Law Firm Announces Consultations for... [Published PRWeb - Nov 12 2013]
1
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Bluegrass Vascular scores $4.5 mln Series A [Published PE Hub Blog - Jul 30 2014]
Bluegrass Vascular Technologies said Wednesday that it has raised $4.5 million in Series A financing. Targeted Technology Fund II led the round. Based in Lexington, Kentucky, Bluegrass Vascular is a medical tech firm focused on developing methods ...
Payment and Delivery Reform Case Study: Cancer ... [Published Brookings Latest From Brookings - Jul 07 2014]
Editor’s note: This post is adapted from a forthcoming full-length case study; the second in a series from the Engelberg Center’s Merkin Initiative on Physician Payment Reform and Clinical Leadership designed to support clinician leadership of health ...
Isis Pharmaceuticals Reports Positive Phase 2 D... [Published PR Newswire: Health - May 22 2014]
CARLSBAD, Calif., May 22, 2014 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced today positive top-line data from a Phase 2 comparator-controlled study evaluating the incidence of venous thrombolic events (VTE) in patients treated ...
GMO Vaccine-Strain Measles vs Cancer [erv] [Published ScienceBlogs : Combined Feed - May 16 2014]
So scientists cured a woman of a pervasive, treatment resistant  multiple myeloma . With a genetically modified, vaccine strain measles virus. Remission of Disseminated Cancer After Systemic Oncolytic Virotherapy *anti-vax-anti-GMOers-heads-explode* ...
Affinity Biologicals Inc. Now Offers a Complete... [Published PR.com Press Releases - Mar 26 2014]
Ancaster, Canada, March 26, 2014 --( PR.com )-- For the last 25 years, Affinity Biologicals is renowned worldwide for its scientific range of products used in thrombosis and hemostasis research and diagnostics. The company is also known for producing ...
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.